Management of biochemically recurrent prostate cancer: Ensuring the right treatment of the right patient at the right time Journal Article


Authors: Spratt, D. E.; McHugh, D. J.; Morris, M. J.; Morgans, A. K.
Article Title: Management of biochemically recurrent prostate cancer: Ensuring the right treatment of the right patient at the right time
Abstract: Biochemically recurrent prostate cancer is an increasingly common disease state, with more than 25,000 cases occurring annually in the United States. Fortunately, progress continues to be made to more effectively identify metastatic disease, optimize existing therapies, and develop new technologies and therapeutic strategies for the timing and delivery of systemic treatments to improve outcomes. This review covers three topics related to the diagnosis and treatment of men with biochemical recurrence (BCR). First, we provide an update on the state of the rapidly evolving field of molecular imaging and its place in practice. Second, we describe validated clinicopathologic methods to risk stratify patients with biochemically recurrent disease, including new gene expression classifiers, to personalize postoperative radiotherapy (RT) timing. Last, we define our approach to optimal management with systemic therapy, including identifying the patients who may benefit most and balancing the duration and timing of treatment with consideration of the effect of therapy on quality of life (QOL) and medical complications associated with treatment.
Keywords: treatment outcome; mortality; multimodality cancer therapy; patient selection; combined modality therapy; recurrence; molecular imaging; tumor marker; prostatic neoplasms; prostate tumor; recurrent disease; disease management; procedures; time to treatment; time-to-treatment; humans; human; male; biomarkers, tumor
Journal Title: American Society of Clinical Oncology Educational Book
Volume: 38
ISSN: 1548-8756
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-23
Start Page: 355
End Page: 362
Language: English
DOI: 10.1200/edbk_200319
PROVIDER: scopus
PUBMED: 30231323
DOI/URL:
Notes: Am Soc Clin Oncol Educ Book -- Export Date: 2 January 2019 -- Review -- Source: Scopus C2 - 30231323
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael Morris
    577 Morris
  2. Deaglan Joseph McHugh
    44 McHugh